Your browser does not fully support modern features. Please upgrade for a smoother experience.
Enhancing Catalytic Activity of Thermo-Asparaginase from Thermococcus sibiricus: Comparison
Please note this is a comparison between Version 2 by Jessie Wu and Version 1 by Alexander Zhgun.

L-asparaginases (L-ASNases) of microbial origin are the mainstay of blood cancer treatment. Numerous attempts have been performed for genetic improvement of the main properties of these enzymes. The substrate-binding Ser residue is highly conserved in L-ASNases regardless of their origin or type. However, the residues adjacent to the substrate-binding Ser differ between mesophilic and thermophilic L-ASNases. 

  • extremophilic enzyme
  • hyperthermophile
  • L-asparaginase
  • substrate-binding
  • mutagenesis
  • enzymatic activity

1. Introduction

Among currently used enzymes, L-asparaginase (L-ASNase) remains one of the most important used in medicine, biosensors, and food industry. L-ASNase (EC 3.5.1.1; L-asparagine amidohydrolase) catalyzes the hydrolysis of L-asparagine (L-Asn) to L-aspartic acid and ammonia [1]. It is the first enzyme with antitumor activity to be used in clinical practice after its approval in 1978 [2,3][2][3]. Currently, L-ASNase continues to be the mainstay for the treatment of pediatric acute lymphoblastic leukemia and is also used to treat other related blood cancers worldwide [4,5][4][5].
L-ASNase therapy is based on L-Asn starvation of susceptible tumor cells that are unable to synthesize their own L-Asn. By hydrolyzing extracellular L-Asn, L-ASNase leads to the death of lymphoblastic cells by apoptosis [6,7][6][7].
Relatively recently, the biotechnological area of L-ASNase application has expanded. In 2002, it was discovered that high contents of acrylamide are formed between reducing sugars and L-asparagine during high-temperature (over 120 °C) processing of starchy foods under low humidity in a non-enzymatic Maillard reaction [8].
By hydrolyzing L-Asn, L-ASNase prevents the formation of carcinogenic acrylamide in the Maillard reaction [9]. As aspartic acid cannot participate in the reaction, L-ASNase treatment helps to reduce the formation of acrylamide in commercially fried foods. The method is safe and effective: L-ASNase treatment leads to a decrease in the content of acrylamide up to 99%, and further heating deactivates the enzyme without affecting the properties of the final product [10,11][10][11].
Another field of the enzyme application is the development of biosensors. Biosensor systems based on L-ASNase allow to detect the level of L-Asn in medicine and in the food industry [12,13][12][13].
Thus, L-ASNase is an enzyme that is widely used in biotechnology under various operating conditions, in particular, in a wide range of temperatures. Most L-ASNases exhibit optimal activity at or near mesophilic temperatures (approximately 30–40 °C) and under mild operating conditions [2]. Obviously, it is difficult for enzymes of mesophilic origin to cover such a wide range of conditions required for their successful application in biotechnology, especially in the food industry. Extremophiles, in particular, thermophiles, which have been reported to produce L-ASNases with unique properties, can expand the number of biotechnologically available L-ASNases [9,14,15,16,17][9][14][15][16][17]. According to experimental data, thermophilic L-ASNases (thermo-ASNases) can not only occupy a vacant niche of high-temperature food technologies but also compete with mesophilic enzymes in biomedicine [9,15,16,17][9][15][16][17].
Due to their superior performance, investigation of thermo-ASNases is of particular interest. Elucidation of the molecular mechanisms that determine the relationship between the activity, stability, and flexibility of thermo-ASNases is critical for both fundamental and applied research in view of their biotechnological significance.
Previously, wresearchers have characterized a new promising hyperthermophilic L-ASNase from the archaea Thermococcus sibiricus (TsA) [16]. The enzyme is optimally active at 90 °C, stable, and exhibits high specific activity and strong cytotoxic activity toward cancer cells.
Various protein engineering approaches are used in an attempt to improve the properties of known L-ASNases. Based on the traditional directed evolution method, Kotzia and Labrou engineered mutants of mesophilic L-ASNases from Erwinia carotovora and Erwinia chrysanthemi [18]. A thermostable mutant Asp133Val was obtained from a library of enzyme variants. This powerful approach is highly dependent on the quality and quantity of the generated libraries, and a target biobetter form is hard to obtain [19,20][19][20]. Enzyme computational engineering approaches can reduce search screening. Offman et al. successfully constructed a proteolysis resistant mutant of Escherichia coli L-ASNase with improved activity by adapting a genetic algorithm of protein modeling in combination with molecular dynamics flexibility studies [21]. The sequence-based approach is a useful technique for engineering desired forms of proteins, in particular with unsolved structures, based on the analysis of well-characterized homologous enzymes. By employing multiple sequences alignment in tandem with homologous modeling, mutant form of Bacillus subtilis L-ASNase with improved thermostability was obtained [22]. Based on sequence alignment and structure superposition of thermophilic and mesophilic L-ASNases, Li et al. identified two residues that affect their thermostability [23].

2. Enhancing the Catalytic Activity of Thermo-Asparaginase from Thermococcus sibiricus 

Mutations usually have a variety of abilities to fine-tune the functions of enzymes [34,35][24][25]. No general guidelines to enhance the activity of the promising wild-type enzyme have been established. For thermo-ASNase TsA, the approach based on the simultaneous mesophilic-like substitutions of residues adjacent to the substrate-binding Ser in the highly conserved DST triad resulted in a 2-fold increase in activity. Homology models revealed that a single mutation—either Asp (thermo-ASNase) → Gly (meso-ASNase EcAII) or Thr (thermo-ASNase) → Gln (meso-ASNase EcAII)—impairs proper substrate binding. Nevertheless, restoring the entire mesophilic-like triad GSQ in TsA after double mutation improved its activity. In EcAII, the downstream residue Gln59 assists the Ser58 residue in substrate binding. In thermo-ASNases, the upstream Asp residue adjacent to the substrate-binding Ser is supposed to play the same role. The puzzle is that, in terms of function, the DST triad is “inverse” in thermo-ASNases compared to mesophilic GSQ relative the substrate-binding Ser. Thus, both previously used mutational strategies in this region to replace single Asp or Thr residue with their directly corresponding residues of EcAII are not entirely correct from the point of increasing activity. In thermo-ASNase PfA, the T53Q mutant is reported to have an increased substrate affinity of 8.3 mM compared to 12.1 mM for the wild-type enzyme. At the same time, the substitution of conservative Thr53 correlates with a more than 2-fold loss in catalytic efficiency [15]. The combination of three adjacent DSQ residues involved in substrate binding and stabilization can lead to an increase in docking strength in thermo-ASNases. At high docking strength, the docking lifetime is longer than the time required for catalysis [36][26]. In turn, in thermo-ASNases Pyrococcus yayanosii (PyA) and Thermococcus gammatolerans (TgA), the Asp → Gly replacement with the resulting “mixed” triad residues GST impaired substrate binding, increased flexibility around the binding Ser residue due to the deficiency of polar contacts [23]. Decreased binding function of the Ser residue caused dramatic loss of PyA and TgA activity (Table 1).

References

  1. Lopes, A.M.; de Oliveira-Nascimento, L.; Ribeiro, A.; Tairum, C.A.; Breyer, C.A.; de Oliveira, M.A.; Monteiro, G.; de Souza-Motta, C.M.; Magalhães, P.d.O.; Avendaño, J.G.F.; et al. Therapeutic l-asparaginase: Upstream, downstream and beyond. Crit. Rev. Biotechnol. 2017, 37, 82–99.
  2. Lubkowski, J.; Wlodawer, A. Structural and biochemical properties of L-asparaginase. FEBS J. 2021, 288, 4183–4209.
  3. Hill, J.M.; Roberts, J.; Loeb, E.; Khan, A.; Maclellan, A.; Hill, R.W. L-Asparaginase Therapy for Leukemia and Other Malignant Neoplasms: Remission in Human Leukemia. JAMA J. Am. Med. Assoc. 1967, 202, 882–888.
  4. Ghasemian, A.; Al-marzoqi, A.H.; Al-abodi, H.R.; Alghanimi, Y.K.; Kadhum, S.A.; Shokouhi Mostafavi, S.K.; Fattahi, A. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives. J. Cell. Physiol. 2019, 234, 19271–19279.
  5. Maggi, M.; Scotti, C. Enzymes in metabolic anticancer therapy. In Advances in Experimental Medicine and Biology; Springer: Berlin/Heidelberg, Germany, 2019; Volume 1148.
  6. Mahajan, R.V.; Kumar, V.; Rajendran, V.; Saran, S.; Ghosh, P.C.; Saxena, R.K. Purification and characterization of a novel and robust L-asparaginase having low-glutaminase activity from bacillus licheniformis: In vitro evaluation of anti-cancerous properties. PLoS ONE 2014, 9, e99037.
  7. Ali, U.; Naveed, M.; Ullah, A.; Ali, K.; Shah, S.A.; Fahad, S.; Mumtaz, A.S. L-asparaginase as a critical component to combat Acute Lymphoblastic Leukaemia (ALL): A novel approach to target ALL. Eur. J. Pharmacol. 2016, 771, 199–210.
  8. Stadler, R.H.; Blank, I.; Varga, N.; Robert, F.; Hau, J.; Guy, P.A.; Robert, M.C.; Riediker, S. Acrylamide from Maillard reaction products. Nature 2002, 419, 449–450.
  9. Sajed, M.; Naeem, S.U.; Rashid, N. L-Asparaginases from hyperthermophilic archaea and their applications. In Microbial Extremozymes; Academic Press: Cambridge, MA, USA, 2022; pp. 177–184.
  10. Gazi, S.; Göncüoğlu Taş, N.; Görgülü, A.; Gökmen, V. Effectiveness of asparaginase on reducing acrylamide formation in bakery products according to their dough type and properties. Food Chem. 2023, 402, 134224.
  11. Mohan Kumar, N.S.; Shimray, C.A.; Indrani, D.; Manonmani, H.K. Reduction of Acrylamide Formation in Sweet Bread with l-Asparaginase Treatment. Food Bioprocess Technol. 2014, 7, 741–748.
  12. Verma, N.; Kumar, K.; Kaur, G.; Anand, S. E. coli K-12 asparaginase-based asparagine biosensor for leukemia. Artif. Cells Blood Substit. Biotechnol. 2007, 35, 449–456.
  13. Kumar, K.; Kataria, M.; Verma, N. Plant asparaginase-based asparagine biosensor for leukemia. Artif. Cells Nanomed. Biotechnol. 2013, 41, 184–188.
  14. Dumina, M.; Zhgun, A. Thermo-L-Asparaginases: From the Role in the Viability of Thermophiles and Hyperthermophiles at High Temperatures to a Molecular Understanding of Their Thermoactivity and Thermostability. Int. J. Mol. Sci. 2023, 24, 2674.
  15. Bansal, S.; Srivastava, A.; Mukherjee, G.; Pandey, R.; Verma, A.K.; Mishra, P.; Kundu, B. Hyperthermophilic asparaginase mutants with enhanced substrate affinity and antineoplastic activity: Structural insights on their mechanism of action. FASEB J. 2012, 26, 1161–1171.
  16. Dumina, M.; Zhgun, A.; Pokrovskaya, M.; Aleksandrova, S.; Zhdanov, D.; Sokolov, N.; El’darov, M. A Novel L-Asparaginase from Hyperthermophilic Archaeon Thermococcus sibiricus: Heterologous Expression and Characterization for Biotechnology Application. Int. J. Mol. Sci. 2021, 22, 9894.
  17. Nadeem, M.S.; Khan, J.A.; Al-Ghamdi, M.A.; Khan, M.I.; Zeyadi, M.A. Studies on the recombinant production and anticancer activity of thermostable L-asparaginase I from Pyrococcus abyssi. Braz. J. Biol. 2022, 82, e244735.
  18. Kotzia, G.A.; Labrou, N.E. Engineering thermal stability of l-asparaginase by in vitro directed evolution. FEBS J. 2009, 276, 1750–1761.
  19. Sen, S.; Venkata Dasu, V.; Mandal, B. Developments in directed evolution for improving enzyme functions. Appl. Biochem. Biotechnol. 2007, 143, 212–223.
  20. Bilal, M.; Iqbal, H.M.N. Tailoring Multipurpose Biocatalysts via Protein Engineering Approaches: A Review. Catal. Lett. 2019, 149, 2204–2217.
  21. Offman, M.N.; Krol, M.; Patel, N.; Krishnan, S.; Liu, J.Z.; Saha, V.; Bates, P.A. Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity. Blood 2011, 117, 1614–1621.
  22. Long, S.; Zhang, X.; Rao, Z.; Chen, K.; Xu, M.; Yang, T.; Yang, S. Amino acid residues adjacent to the catalytic cavity of tetramer l-asparaginase II contribute significantly to its catalytic efficiency and thermostability. Enzyme Microb. Technol. 2016, 82, 15–22.
  23. Li, X.; Zhang, X.; Xu, S.; Xu, M.; Yang, T.; Wang, L.; Zhang, H.; Fang, H.; Osire, T.; Rao, Z. Insight into the thermostability of thermophilic L-asparaginase and non-thermophilic L-asparaginase II through bioinformatics and structural analysis. Appl. Microbiol. Biotechnol. 2019, 103, 7055–7070.
  24. Pokrovskaya, M.V.; Pokrovsky, V.S.; Aleksandrova, S.S.; Sokolov, N.N.; Zhdanov, D.D. Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions. Pharmaceutics 2022, 14, 599.
  25. Li, Y.; Song, K.; Zhang, J.; Lu, S. A computational method to predict effects of residue mutations on the catalytic efficiency of hydrolases. Catalysts 2021, 11, 286.
  26. Dyla, M.; González Foutel, N.S.; Otzen, D.E.; Kjaergaard, M. The optimal docking strength for reversibly tethered kinases. Proc. Natl. Acad. Sci. USA 2022, 119, e2203098119.
  27. Kengen, S.W.M. Pyrococcus furiosus, 30 years on. Microb. Biotechnol. 2017, 10, 1441–1444.
  28. Borek, D.; Kozak, M.; Pei, J.; Jaskolski, M. Crystal structure of active site mutant of antileukemic L-asparaginase reveals conserved zinc-binding site. FEBS J. 2014, 281, 4097–4111.
  29. Sanches, M.; Barbosa, J.A.R.G.; De Oliveira, R.T.; Neto, J.A.; Polikarpov, I. Structural comparison of Escherichia coli L-asparaginase in two monoclinic space groups. Acta Crystallogr. Sect. D Biol. Crystallogr. 2003, 59, 416–422.
  30. Geiger, T.; Clarke, S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 1987, 262, 785–794.
  31. Vieille, C.; Zeikus, G.J. Hyperthermophilic Enzymes: Sources, Uses, and Molecular Mechanisms for Thermostability. Microbiol. Mol. Biol. Rev. 2001, 65, 1–43.
  32. Dumina, M.V.; Eldarov, M.A.; Zdanov, D.D.; Sokolov, N.N. L-Asparaginases of Extremophilic Microorganisms in Biomedicine. Biochem. Suppl. Ser. B Biomed. Chem. 2020, 14, 33.
More
Academic Video Service